Upstream Bio (UPB) Total Liabilities (2023 - 2025)
Historic Total Liabilities for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $12.6 million.
- Upstream Bio's Total Liabilities rose 390.54% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 390.54%. This contributed to the annual value of $11.9 million for FY2024, which is 2639.26% up from last year.
- Per Upstream Bio's latest filing, its Total Liabilities stood at $12.6 million for Q3 2025, which was up 390.54% from $11.8 million recorded in Q2 2025.
- Upstream Bio's Total Liabilities' 5-year high stood at $146.6 million during Q2 2024, with a 5-year trough of $9.4 million in Q4 2023.
- Its 3-year average for Total Liabilities is $51.2 million, with a median of $12.1 million in 2024.
- In the last 5 years, Upstream Bio's Total Liabilities soared by 2639.26% in 2024 and then crashed by 9208.51% in 2025.
- Quarter analysis of 3 years shows Upstream Bio's Total Liabilities stood at $9.4 million in 2023, then grew by 26.39% to $11.9 million in 2024, then increased by 6.27% to $12.6 million in 2025.
- Its last three reported values are $12.6 million in Q3 2025, $11.8 million for Q2 2025, and $10.6 million during Q1 2025.